Context Therapeutics (CNTX) said Monday it has appointed Andy Pasternak as chairman of its board of directors, succeeding Richard Berman who stepped down on Jan. 12.
Pasternak currently serves as an advisory partner at Bain & Company, the company said.
Shares of Context Therapeutics were down nearly 4% in recent Monday premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.